Financials
- Market Capitalization 44.98 B
- Employee 883
- Founded 2014
- CEO N/A
- Website www.revmed.com
- Headquarter Delaware, United States
- FIGI BBG00829F4P8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-21.14
ratio cours/chiffre d'affaires
9 695.31
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 262 | ARGX argenx SE - American Depositary Shares | 1028.51 USD | -0.31% | -0.46% | +22.61% | +44.66% | 63.65 B USD | ||
| 270 | MRNA Moderna, Inc. - Common Stock | 154.27 USD | +9.93% | -0.16% | +180.85% | +538.80% | 61.59 B USD | ||
| 432 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 246.11 USD | +2.25% | +2.30% | +18.30% | -44.67% | 32.93 B USD | ||
| 478 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 62.32 USD | +1.48% | +0.50% | +7.34% | +67.26% | 27.83 B USD |